Vanqua Bio
Omer Siddiqui is an accomplished professional in the biopharmaceutical industry, currently serving as Chief Development Officer at Vanqua Bio since April 2023. Prior experience includes roles as Vice President at Harpoon Therapeutics, where responsibilities encompassed leading study management, contracts, and project management, and at Alector as Vice President, Head of Development Operations, focusing on clinical strategy and execution. Omer has also held key positions at Allakos Inc, Genentech, and INC Research, demonstrating extensive expertise in clinical operations and program development across various therapeutic areas. Educationally, Omer holds a Master of Science in Biotechnology from The Johns Hopkins University and a Bachelor of Science in Biology from Western University.
This person is not in any offices
Vanqua Bio
Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).